We upgrade Philips to Buy, as litigation overhangs are resolved, FCF inflects positively, and deleveraging is on track. Q1 results show early U.S. recovery, margin resilience, and order book growth, despite China weakness and FX headwinds. Exor's increased stake underscores long-term shareholder confidence.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) shares soared in Wednesday afternoon's trading, after putting the spotlight on its ongoing collaboration with Philips, The Dutch electronics firm is to broaden its use of Polarean's Xenon lung MRI technology to include younger children with chronic obstructive lung disease, subject to regulatory clearance. Philips said it is integrating the Xenon MRI platform into its 3.0T MRI systems to support non-invasive, radiation-free imaging.
PHG's first-quarter results reflect a decline in sales and earnings due to weaker demand in China, leading to lowered 2025 guidance and a cautious outlook.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Koninklijke Philips N.V. (NYSE:PHG ) Q1 2025 Earnings Conference Call May 6, 2025 4:00 AM ET Company Participants Durga Doraisamy - Head-Investor Relations Roy Jakobs - President & Chief Executive Officer Charlotte Hanneman - Executive Vice President & Chief Financial Officer Conference Call Participants Richard Felton - Goldman Sachs David Adlington - JPMorgan Veronika Dubajova - Citi Hassan Al-Wakeel - Barclays Graham Doyle - UBS Lisa Clive - Bernstein Julien Dormois - Jefferies Robert Davies - Morgan Stanley Hugo Solvet - BNP Paribas Exane Wim Gille - ABN ODDO Julien Ouaddour - Bank of America Sezgi Oezener - HSBC Falko Friedrichs - Deutsche Bank Operator Welcome to The Royal Philips' First Quarter 2025 Results Conference Call on Tuesday, May 6, 2025.
Shares of medical equipment company Koninklijke Philips (PHG) shares are dropping Tuesday after the Dutch conglomerate said it had cut its target profit margin due to tariffs.
Philips faces risks from sluggish Chinese sales, trade war impacts, and potential new scandals, but cost-cutting and AI integration offer growth opportunities. Recent results show flat sales but improved adjusted EBITA margins, with significant challenges in China offset by strength in other markets. Philips expects modest sales growth and margin improvements by 2025, despite ongoing concerns in China and settlement-related cash flow pressures.
Philips expands cloud-based imaging in Europe, enhancing AI-driven workflows, collaboration and efficiency in radiology.
PHG's fourth-quarter results reflect a decline in sales and earnings due to weaker demand in China, leading to lowered 2025 guidance and a cautious outlook.
Koninklijke Philips N.V. (NYSE:PHG ) Q4 2024 Earnings Call Transcript February 19, 2025 3:00 AM ET Company Participants Leandro Mazzoni - Head of Investor Relations Roy Jakobs - Chief Executive Officer Charlotte Hanneman - CFO Conference Call Participants Richard Felton - Goldman Sachs David Adlington - JP Morgan Hassan Al-Wakeel - Barclays Julien Dormois - Jefferies Lisa Clive - Bernstein Robert Davies - Morgan Stanley Graham Doyle - UBS Hugo Solvet - BNP Paribas Exane Giang Nguyen - Citi Julien Ouaddour - Bank of America Wim Gille - ABN AMRO ODDO Operator Welcome to The Royal Philips' Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, February 19, 2025.
Roy Jakobs, Royal Philips CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
Dutch healthcare technology group Koninklijke Philips NV PHG stock is trading lower on Wednesday after the fourth quarter earnings missed expectations.